BenchSci

BenchSci is a Toronto-based company that specializes in the development and provision of machine learning software for life science research. Their flagship product is an AI-powered antibody search engine, which aids researchers in finding reliable antibodies faster and more efficiently. This tool significantly reduces the time spent on literature review and helps avoid failed experiments, thereby accelerating biomedical discovery.

The company's software uses machine learning to understand the context of antibody use within research papers, which allows it to suggest more reliable antibodies for specific experiments. BenchSci is dedicated to helping scientists and researchers, with its platform currently used by over 31,000 researchers at more than 3,600 academic institutions and 15 of the top 20 pharmaceutical companies. The goal of the company is to empower scientists to make more informed decisions, thereby driving quicker, more reliable research outcomes.